MarketCapTrends
UTHR

United Therapeutics Corporation (UTHR)

NASDAQ · Healthcare

United Therapeutics Corporation annual/quarterly shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • United Therapeutics Corporation shareholder equity for the quarter ending December 31, 2025 were 7.10B, a 10.12% increase year-over-year.
  • United Therapeutics Corporation shareholder equity for 2025 were 7.10B, a 10.12% increase from 2024.
  • United Therapeutics Corporation shareholder equity for 2024 were 6.44B, a 7.67% increase from 2023.
  • United Therapeutics Corporation shareholder equity for 2023 were 5.98B, a 24.77% increase from 2022.
  • United Therapeutics Corporation shareholder equity for 2022 were 4.80B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
United Therapeutics Corporation Annual Shareholder Equity (Millions of US $)
2025$7,096
2024$6,444
2023$5,985
2022$4,797
2021$3,959
2020$3,395
2019$2,780
2018$2,789
2017$2,102
2016$1,851
2015$1,589
2014$1,243
2013$1,259
2012$1,084
2011$948
United Therapeutics Corporation Quarterly Shareholder Equity (Millions of US $)
2025-12-31$7,096
2024-12-31$6,444
2023-12-31$5,985
2022-12-31$4,797
2021-12-31$3,959
2020-12-31$3,395
2019-12-31$2,780
2018-12-31$2,789
2017-12-31$2,102
2016-12-31$1,851
2015-12-31$1,589
2014-12-31$1,243
2013-12-31$1,259
2012-12-31$1,084
2011-12-31$948
2010-12-31$884
2009-12-31$653

United Therapeutics Corporation Shareholder Equity — FAQ

United Therapeutics Corporation (UTHR) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see UTHR's shareholder equity history?

The chart and table above show United Therapeutics Corporation's shareholder equity by year and by quarter, including the growth rate.